Brief: Caplin Point Laboratories Approves Slump Sale Of Co's Business Undertaking To Unit
Nov 19 (Reuters) - Caplin Point Laboratories Ltd CAPL.NS :
* APPROVED SLUMP SALE OF BUSINESS UNDERTAKING OF CO TO UNIT
WHICH
IS IN PROCESS OF BEING INCORPORATED
* SALE EXPECTED TO BE COMPLETED BY JAN 2019
* REGULATED MARKETS INJECTABLE BUSINESS OF CO TO BE
TRANSFERRED
FOR A LUMP SUM
Source text: http://bit.ly/2KeTe6k
Further company coverage: CAPL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Caplin Point Laboratories
See all newsBrief: Caplin Point Laboratories Says US FDA Completes Unannounced Inspection Of Caplin Steriles Gummidipoondi Facility
Brief: Caplin Point Laboratories March-Quarter Consol Net Profit 1.7 Bln Rupees
Brief: Caplin Point Laboratories Unit Receives Final USFDA Approval For ANDA Potassium Phosphates Injection
Brief: Caplin Point Laboratories Says Unit Receives USFDA Approval For Sodium Phosphates Injection
Brief: Caplin Point Laboratories Dec-Quarter Consol Net Profit 1.64 Billion Rupees